Drug and pharmaceutical recalls
17747 federal recalls on file. Federal recalls for prescription drugs, OTC medications, supplements, and pharmaceuticals. Sourced from the FDA and translated into plain English.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIPyridoxine 100mg/ml Inj MDV, 1X30 ml 30 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIMeperidine 100mg/ml MDV, 5ml 90 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IILidocaine 2% Inj MDV, 20 ml 30 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIM.I.C.+B12 Inj MDV: 3x50ml, 4x50 ml 90 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIGlutathione 200mg/ml Inj SDV: 3x50ml 14 day expiration, 1x50ml 21 day expiration
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIGentamicin 24mg/60ml Irrigation, 15x60ml Syr Irrigation, 14 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIRenacidin Irrigation: 1000 ml,1120ml Bladder Irrigation, 30 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIHydroxyprogesterone Inj 250mg/ml MDV, 5 ml Intramuscular, 30 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIMethylcobalamin Inj 25mg/ml Syr: 8x0.06mlsyr, 10x0.06 ml syr, 12x0.06 ml syr Subcutaneous, 30 and 90 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIMethylcobalamin Inj 2.5mg/ml MDV, 10 ml Subcutaneous, 90 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIMethylcobalamin 5mg/ml Inj Syr, 10x0.4syr Subcutaneous, 90 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIMethylcobalamin Inj 5mg/ml MDV: 5 ml, 10 ml, 12 ml, 20 ml Subcutaneous, 90 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIMethylcobalamin Inj 1mg/ml MDV, 10 ml, 15 ml, 20 ml, 30 ml, 4x30 ml Subcutaneous, 90 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIHydroxycobalamin Inj 2500 mcg/ml MDV, 2x30ml Subcutaneous, 90 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIHydroxycobalamin Inj 1 mcg/ml MDV, 2x30ml Subcutaneous, 90 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIHydroxycobalamin Inj 1000mcg/ml MDV: 10 ml, 15 ml, 20 ml, 30 ml Subcutaneous, 90 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIHCG Inj 500un/ml MDV, 5 ml Subcutaneous, 30 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIHCG Inj 1250 un/ml MDV, 4 ml Subcutaneous, 30 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIHCG Inj 1200un/ml MDV, 10 ml Subcutaneous, 30 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIHCG Inj 1000un/ml MDV: 4ml, 8 ml Subcutaneous, 30 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIFolic Acid Inj 5mg/ml MDV, 10 ml Subcutaneous, 90 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIPHMB Opth Soln 0.02%, 10 ml Opthalmic Soln, 30 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIDexamethasone Opth Soln 0.1% PF, 10 ml Opthalmic Soln, 30 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIChlorhexidine Opth Soln 0.02%, 10 ml Opthalmic Soln, 30 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IITobramycin Opth Soln 13mg/ml, 7ml Opthalmic Soln, 10 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IITobramycin Opth Soln 14mg/ml, 7ml Opthalmic Soln, 10 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIVancomycin Opth Soln14mg/ml PF, 10ml Opthalmic Soln, 30 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIVancomycin Opth Soln 30mg/ml PRES, 10ml Opthalmic Soln, 30 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IIVancomycin Opth Soln 25mg/ml PF, 10ml Opthalmic Soln, 10 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
- 2013-06-05FDA-DrugNora Apothecary and Alternative Therapies, Inc.Class IISuper Trimix #1 Inj MDV, 12 ml Penile Injection, 90 day expiration,
Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes.
Get notified about new drug recalls
Free weekly digest. We email when a new federal recall in this category — or anything else affecting your household — is published.
Get the Sunday Brief